The Cancer Letter

Inside information on cancer research and drug development

Drugs & Targets

Lifebit, Flatiron Health partner to accelerate cancer data research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Lifebit and Flatiron Health are partnering to support vital research and enable scientific discoveries to improve and extend lives by learning from the experiences of people with cancer. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Drugs & Targets

Flatiron partners with Leeds Teaching Hospitals NHS Trust

Flatiron Health is partnering with Leeds Teaching Hospitals NHS Trust, one of largest acute hospital trusts in Europe.  “Alongside partners, regulators, and patient advocates—and with scalable and secure methods—Flatiron has developed a unique offering in the UK to translate data from routine clinical care into research-ready datasets,” Flatiron CEO Carolyn Starrett said in a statement....

Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account